Search

Christopher W. Fulton

Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856
Total Applications
3373
Issued Applications
2875
Pending Applications
85
Abandoned Applications
419

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7573024 [patent_doc_number] => 20110268680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'HEAT STABLE PROTEIN INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/098694 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 14127 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268680.pdf [firstpage_image] =>[orig_patent_app_number] => 13098694 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/098694
Heat stable protein ingredients May 1, 2011 Issued
Array ( [id] => 6090358 [patent_doc_number] => 20110218148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/079400 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11547 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218148.pdf [firstpage_image] =>[orig_patent_app_number] => 13079400 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/079400
PHARMACEUTICAL COMPOSITION Apr 3, 2011 Abandoned
Array ( [id] => 8128621 [patent_doc_number] => 20120088848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR CONTROLLED POLYPEPTIDE SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 13/076953 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36789 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088848.pdf [firstpage_image] =>[orig_patent_app_number] => 13076953 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/076953
METHODS AND COMPOSITIONS FOR CONTROLLED POLYPEPTIDE SYNTHESIS Mar 30, 2011 Abandoned
Array ( [id] => 7697084 [patent_doc_number] => 20110229506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'METHOD FOR CANCER IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/053996 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229506.pdf [firstpage_image] =>[orig_patent_app_number] => 13053996 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/053996
Method for cancer immunotherapy Mar 21, 2011 Issued
Array ( [id] => 6189800 [patent_doc_number] => 20110172157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'SOMATOSTATIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/048932 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8547 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172157.pdf [firstpage_image] =>[orig_patent_app_number] => 13048932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/048932
Somatostatin analogues Mar 15, 2011 Issued
Array ( [id] => 6102827 [patent_doc_number] => 20110166320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'SOMATOSTATIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/048935 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8545 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166320.pdf [firstpage_image] =>[orig_patent_app_number] => 13048935 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/048935
Somatostatin analogues Mar 15, 2011 Issued
Array ( [id] => 10110068 [patent_doc_number] => 09145472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Charge reversible polymers' [patent_app_type] => utility [patent_app_number] => 13/033247 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 6806 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13033247 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/033247
Charge reversible polymers Feb 22, 2011 Issued
Array ( [id] => 7663609 [patent_doc_number] => 20110312878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS' [patent_app_type] => utility [patent_app_number] => 13/027475 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31051 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312878.pdf [firstpage_image] =>[orig_patent_app_number] => 13027475 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/027475
PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS Feb 14, 2011 Abandoned
Array ( [id] => 9427835 [patent_doc_number] => 08703912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Processes for removal of dibenzofulvene' [patent_app_type] => utility [patent_app_number] => 13/020838 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13020838 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/020838
Processes for removal of dibenzofulvene Feb 3, 2011 Issued
Array ( [id] => 6002807 [patent_doc_number] => 20110118179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'CATION COMPLEXES OF INSULIN COMPOUND CONJUGATES, FORMULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/012146 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 57251 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118179.pdf [firstpage_image] =>[orig_patent_app_number] => 13012146 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/012146
Cation complexes of insulin compound conjugates, formulations and uses thereof Jan 23, 2011 Issued
Array ( [id] => 6186190 [patent_doc_number] => 20110124553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/008094 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 57027 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124553.pdf [firstpage_image] =>[orig_patent_app_number] => 13008094 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/008094
Insulin-oligomer conjugates, formulations and uses thereof Jan 17, 2011 Issued
Array ( [id] => 6187755 [patent_doc_number] => 20110171196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN' [patent_app_type] => utility [patent_app_number] => 12/984421 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21155 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171196.pdf [firstpage_image] =>[orig_patent_app_number] => 12984421 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/984421
METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN Jan 3, 2011 Abandoned
Array ( [id] => 5968970 [patent_doc_number] => 20110150837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Amphiphilic polymer functionalized by methionine' [patent_app_type] => utility [patent_app_number] => 12/977816 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6030 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150837.pdf [firstpage_image] =>[orig_patent_app_number] => 12977816 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/977816
Amphiphilic polymer functionalized by methionine Dec 22, 2010 Abandoned
Array ( [id] => 6000611 [patent_doc_number] => 20110117057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 12/973020 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37463 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117057.pdf [firstpage_image] =>[orig_patent_app_number] => 12973020 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/973020
NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS Dec 19, 2010 Abandoned
Array ( [id] => 5972495 [patent_doc_number] => 20110152188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF IGF/I PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/969619 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7918 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152188.pdf [firstpage_image] =>[orig_patent_app_number] => 12969619 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/969619
PHARMACEUTICAL COMPOSITIONS OF IGF/I PROTEINS Dec 15, 2010 Abandoned
Array ( [id] => 5944781 [patent_doc_number] => 20110105401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'PEPTIDE COMPOSITION AND A METHOD OF PROMOTING CARTILAGE FORMATION' [patent_app_type] => utility [patent_app_number] => 12/968532 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17175 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105401.pdf [firstpage_image] =>[orig_patent_app_number] => 12968532 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/968532
Peptide composition and a method of promoting cartilage formation Dec 14, 2010 Issued
Array ( [id] => 6083598 [patent_doc_number] => 20110144014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'CYTOKINE RECEPTOR MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/968363 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 44922 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144014.pdf [firstpage_image] =>[orig_patent_app_number] => 12968363 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/968363
CYTOKINE RECEPTOR MODULATORS AND USES THEREOF Dec 14, 2010 Abandoned
Array ( [id] => 5985671 [patent_doc_number] => 20110097805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'KOKUMI-IMPARTING AGENT' [patent_app_type] => utility [patent_app_number] => 12/962051 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11922 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097805.pdf [firstpage_image] =>[orig_patent_app_number] => 12962051 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/962051
Kokumi-imparting agent Dec 6, 2010 Issued
Array ( [id] => 6080235 [patent_doc_number] => 20110142895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'TRIPEPTIDES AND DERIVATIVES THEREOF FOR COSMETIC APPLICATION IN ORDER TO IMPROVE SKIN STRUCTURE' [patent_app_type] => utility [patent_app_number] => 12/954142 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8362 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142895.pdf [firstpage_image] =>[orig_patent_app_number] => 12954142 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/954142
Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure Nov 23, 2010 Issued
Array ( [id] => 6083595 [patent_doc_number] => 20110144012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'SHORTENED GLUCAGON-LIKE PEPTIDE 1(SGLP-1) PREPARATION METHOD AND APPLICATION' [patent_app_type] => utility [patent_app_number] => 12/946677 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3575 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144012.pdf [firstpage_image] =>[orig_patent_app_number] => 12946677 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/946677
SHORTENED GLUCAGON-LIKE PEPTIDE 1(SGLP-1) PREPARATION METHOD AND APPLICATION Nov 14, 2010 Abandoned
Menu